image description

Tag: National Institutes of Health

House Approves $10 Million for Lupus Research Funding!

July 31, 2020 In early July we alerted you that the Fiscal Year (FY) 2021 Defense Appropriations Bill was publicly announced with $10 million appropriated for the Lupus Research Program at the Department of Defense. We are thrilled to announce that the House of Representatives today passed this Bill! The many, many phone calls and […] Read More

LRA Partnering with NIH, FNIH and Others on Groundbreaking Initiative

December 9, 2021 The Lupus Research Alliance (LRA) is proud and excited to partner again with the National Institutes of Health (NIH), the Foundation for the National Institutes of Health (FNIH), and others on a new program – Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) – that will apply new cutting-edge tools to […] Read More

Lupus Advocacy Delivers Again!

December 28, 2020 After much back and forth, last week the U.S. Congress passed the year-end spending deal, called the Omnibus, and President Trump signed it into law Sunday night.  It’s because of your efforts during the LRA’s Virtual Hill Day in March that the need to fund research for lupus and other medical conditions […] Read More

It’s Not Too Late to Advocate for Lupus Research!

March, 2020 Congress will be working on the Fiscal Year 2021 budget for weeks to come, so you can still make your voice heard for lupus research.  If you haven’t already, please go online TODAY and use the automated tools of our Legislative Action Center to tell legislators what lupus research means to their constituents […] Read More

Accelerating Medicines Partnership Completes Key Phase

September 24, 2019 The Accelerating Medicines Partnership (AMP) RA/Lupus Program, a joint effort involving the National Institutes of Health (NIH), the Foundation for NIH, pharmaceutical companies, and non-profit organizations such as the Lupus Research Alliance, has reached a milestone, finishing an important phase of its studies. Researchers with the AMP RA/Lupus Program have published a […] Read More

NIH Work Co-Supported by LRA May Simplify Lupus Nephritis Monitoring

June 20, 2019 As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) “provides new insights into tissue damage for these autoimmune conditions.” AMP RA/SLE is a public-private partnership between the NIH, the pharmaceutical industry and non-profit organizations, including the Lupus […] Read More

Lupus Research Alliance Congratulates NIH on 5-Year AMP Success

February 28, 2019 NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership (AMP), the Lupus Research Alliance is proud to share the project’s five-year achievements reported in Nature Reviews Drug Discovery.  In the article, NIH Director Dr. Francis Collins points to new technology standards AMP created for […] Read More

Lupus Research Alliance Advocates Win Big with 2019 Federal Funding

NEW YORK, NY. Sept. 28 – Congratulations go out to the Lupus Research Alliance advocates! The 2019 spending bill was signed into law today, granting the two requests Lupus Research Alliance advocates made to legislators on “Capitol Hill Day” in March 2018. Approved by Congress earlier in the week, the bill provides $5 million for […] Read More